Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Gross Profit (2016 - 2025)

Historic Gross Profit for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $95.0 million.

  • Mimedx's Gross Profit rose 3822.07% to $95.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $322.6 million, marking a year-over-year increase of 1286.78%. This contributed to the annual value of $288.8 million for FY2024, which is 823.07% up from last year.
  • As of Q3 2025, Mimedx's Gross Profit stood at $95.0 million, which was up 3822.07% from $79.9 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Gross Profit ranged from a high of $95.0 million in Q3 2025 and a low of $43.7 million during Q4 2021
  • Over the past 5 years, Mimedx's median Gross Profit value was $66.9 million (recorded in 2023), while the average stood at $64.4 million.
  • Per our database at Business Quant, Mimedx's Gross Profit crashed by 2427.68% in 2021 and then surged by 3822.07% in 2025.
  • Mimedx's Gross Profit (Quarter) stood at $43.7 million in 2021, then surged by 37.27% to $60.0 million in 2022, then rose by 21.64% to $73.0 million in 2023, then rose by 4.12% to $76.0 million in 2024, then grew by 25.01% to $95.0 million in 2025.
  • Its Gross Profit stands at $95.0 million for Q3 2025, versus $79.9 million for Q2 2025 and $71.6 million for Q1 2025.